AI Science Tracker
EN

A machine learning-assisted hypoxia-associated prognostic model reveals PFKP-mediated glycolytic regulation in uveal melanoma

Affiliation not stated in the reviewed material · 5 Nov 2026 · medicine

Discovery

A machine learning-assisted hypoxia-associated prognostic model reveals PFKP-mediated glycolytic regulation in uveal melanoma

Source check: Source checked. Not independent scientific confirmation.

Finding: In a TCGA uveal-melanoma cohort (n=80), machine-learning approaches nominated prognostic candidates; ENO3/PFKP were evaluated in an independent cohort. PFKP perturbation experiments reported changes in proliferation, glycolysis and xenograft growth. Author affiliations were not available in the reviewed publisher passages; organization left empty.

Technology: Five machine-learning survival approaches; multivariable Cox modeling

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Five machine-learning survival approaches; multivariable Cox modeling
Test and result
In a TCGA uveal-melanoma cohort (n=80), machine-learning approaches nominated prognostic candidates; ENO3/PFKP were evaluated in an independent cohort. PFKP perturbation experiments reported changes in proliferation, glycolysis and xenograft growth.
Limitation / still unknown
The prognostic associations and experimental perturbations do not establish the full human disease mechanism.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1993731/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.